Citrullination
Products Related to Citrullination(20)
- GC40255Citrulline-specific Probe-biotinCAS: 2468149-70-2Purity: >75.00%
Citrulline-specific probe-biotin is an affinity probe that allows for detection or immobilization of citrullinated proteins through interaction with the biotin ligand.
- GC43275Citrulline-specific Probe-RhodamineCAS: 2309313-01-5Purity: >90.00%
Protein arginine deiminases (PADs) catalyze the posttranslational modification of arginine residues on proteins to form citrulline, which plays a large role in regulating gene expression.
- GC43651F-Amidine (trifluoroacetate salt)CAS: 877617-46-4Purity: >95.00%
F-amidine is an inhibitor of protein arginine deiminases (PADs) that is selective for PAD1 and PAD4 (IC50s = 29.5, 350, and 21.6 μM for PAD1, PAD3, and PAD4 in vitro, respectively).
- GC43787GSK106 (hydrochloride)CAS: 1652591-82-6Purity: >98.00%
GSK106 (hydrochloride) is an inactive control for the selective PAD4 inhibitors, GSK484 and GSK199.
- GC43788GSK121 (trifluoroacetate salt)CAS: 1652591-80-4Purity: >98.00%
GSK-121 Trifluoroacetates a selective PAD4 inhibitor.
- GC43789GSK199 (hydrochloride)CAS: 1549811-53-1Purity: >98.00%
GSK199 (hydrochloride) is an orally active and reversible selective peptidyl arginine deiminase 4 (PAD4) inhibitor with an IC 50 value of 200nM in the absence of calcium ions.
- GC52351Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide
A biotinylated and citrullinated α-enolase peptide
- GC52363Citrullinated Histone H3 (R2 + R8 + R17) (2-22)-biotin Peptide
A biotinylated and citrullinated histone H3 peptide
- GC52367Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin PeptidePurity: >99.00%
A biotinylated and citrullinated mutant vimentin peptide
- GC52370Citrullinated Vimentin (R144) (139-159)-biotin PeptidePurity: >98.00%
A biotinylated and citrullinated vimentin peptide
- GC52371Vimentin (G146R) (139-159)-biotin PeptidePurity: >98.00%
A biotinylated mutant vimentin peptide
- GC91565GSK199 analog (hydrochloride)CAS: 2048226-46-4Purity: >95.00%
GSK199 analog is an inhibitor of peptidyl arginine deiminase 4 (PAD4) and a derivative of the PAD4 inhibitor GSK199.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC40255 | Citrulline-specific Probe-biotin | 2468149-70-2 | >75.00% | |
Citrulline-specific probe-biotin is an affinity probe that allows for detection or immobilization of citrullinated proteins through interaction with the biotin ligand. | ||||
| GC43202 | CAY10723 | 2095107-57-4 | >98.00% | |
CAY10723 is a potent protein arginine deiminase 2 (PAD2) inhibitor and has excellent PAD2-selectivity. | ||||
| GC43275 | Citrulline-specific Probe-Rhodamine | 2309313-01-5 | >90.00% | |
Protein arginine deiminases (PADs) catalyze the posttranslational modification of arginine residues on proteins to form citrulline, which plays a large role in regulating gene expression. | ||||
| GC43651 | F-Amidine (trifluoroacetate salt) | 877617-46-4 | >95.00% | |
F-amidine is an inhibitor of protein arginine deiminases (PADs) that is selective for PAD1 and PAD4 (IC50s = 29.5, 350, and 21.6 μM for PAD1, PAD3, and PAD4 in vitro, respectively). | ||||
| GC43787 | GSK106 (hydrochloride) | 1652591-82-6 | >98.00% | |
GSK106 (hydrochloride) is an inactive control for the selective PAD4 inhibitors, GSK484 and GSK199. | ||||
| GC43788 | GSK121 (trifluoroacetate salt) | 1652591-80-4 | >98.00% | |
GSK-121 Trifluoroacetates a selective PAD4 inhibitor. | ||||
| GC43789 | GSK199 (hydrochloride) | 1549811-53-1 | >98.00% | |
GSK199 (hydrochloride) is an orally active and reversible selective peptidyl arginine deiminase 4 (PAD4) inhibitor with an IC 50 value of 200nM in the absence of calcium ions. | ||||
| GC45005 | TDFA (trifluoroacetate salt) | - | >98.00% | |
| GC45402 | CAY10729 (trifluoroacetate salt) (technical grade) | - | >70.00% | |
| ||||
| GC45548 | Photoswitchable PAD Inhibitor (technical grade) | 2226393-62-8 | >70.00% | |
| ||||
| GC47050 | CAY10727 | 1671088-84-8 | >90.00% | |
A PAD3 inhibitor | ||||
| GC48495 | BMS-P5 | 1550371-22-6 | >99.50% | |
BMS-P5 is a novel, orally active selective inhibitor of peptidylarginine deiminase 4 (PAD4) with an IC 50 of 98nM. | ||||
| GC52351 | Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide | - | - | |
A biotinylated and citrullinated α-enolase peptide | ||||
| GC52363 | Citrullinated Histone H3 (R2 + R8 + R17) (2-22)-biotin Peptide | - | - | |
A biotinylated and citrullinated histone H3 peptide | ||||
| GC52364 | Vimentin (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated vimentin peptide | ||||
| GC52367 | Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide | - | >99.00% | |
A biotinylated and citrullinated mutant vimentin peptide | ||||
| GC52370 | Citrullinated Vimentin (R144) (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated and citrullinated vimentin peptide | ||||
| GC52371 | Vimentin (G146R) (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated mutant vimentin peptide | ||||
| GC90710 | CAY10723 (hydrochloride) | - | >95.00% | |
A PAD2 inhibitor | ||||
| GC91565 | GSK199 analog (hydrochloride) | 2048226-46-4 | >95.00% | |
GSK199 analog is an inhibitor of peptidyl arginine deiminase 4 (PAD4) and a derivative of the PAD4 inhibitor GSK199. | ||||